Seres Therapeutics

MCRBNASDAQ
$0.950651
-0.02-2.32%
Last update: 11:09 AM
15 minutes delayed

Seres Therapeutics (NASDAQ:MCRB) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for Seres Therapeutics (MCRB)?

A

There have been no specific sales or earnings guidance reported for Seres Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch